ORSOBIO, INC.

Address: 101 JEFFERSON DR MENLO PARK, CA 94025-1114
County: SAN MATEO
Country: UNITED STATES
UEI: QELBLKZEHL99

Issue Date FY

Legal Entity Zip Code

Issue Date FY: 2026 ( Subtotal = $0 )

2026

2024

ORSOBIO, INC.

101 JEFFERSON DR

MENLO PARK

94025-1114

SAN MATEO

USA

R44DK135174

TLC-1235, a controlled-release mitochondrial protonophore (CRMP), for the reversal of insulin resistance in patients with severe lipodystrophy

000

NIH

11/19/2025

Issue Date FY: 2025 ( Subtotal = $0 )

2025

2022

ORSOBIO, INC.

101 JEFFERSON DR

MENLO PARK

94025-1114

SAN MATEO

USA

R44DK135174

TLC-1235, a controlled-release mitochondrial protonophore (CRMP), for the reversal of insulin resistance in patients with severe lipodystrophy

000

NIH

2/12/2025

Issue Date FY: 2024 ( Subtotal = $999,999 )

2024

ORSOBIO, INC.

101 JEFFERSON DR

MENLO PARK

94025-1114

SAN MATEO

USA

R44DK135174

TLC-1235, a controlled-release mitochondrial protonophore (CRMP), for the reversal of insulin resistance in patients with severe lipodystrophy

000

NIH

8/16/2024

$999,999

Issue Date FY: 2023 ( Subtotal = $999,999 )

2023

ORSOBIO, INC.

101 JEFFERSON DR

MENLO PARK

94025-1114

SAN MATEO

USA

R44DK135174

TLC-1235, a controlled-release mitochondrial protonophore (CRMP), for the reversal of insulin resistance in patients with severe lipodystrophy

002

NIH

9/8/2023

$999,999

2023

2022

ORSOBIO, INC.

101 JEFFERSON DR

MENLO PARK

94025-1114

SAN MATEO

USA

R44DK135174

TLC-1235, a controlled-release mitochondrial protonophore (CRMP), for the reversal of insulin resistance in patients with severe lipodystrophy

001

NIH

8/18/2023

2023

2022

LIVER COMPANY INC., THE

2671 MARSHALL DR

PALO ALTO

94303-3654

SANTA CLARA

USA

R44DK135174

TLC-1235, a controlled-release mitochondrial protonophore (CRMP), for the reversal of insulin resistance in patients with severe lipodystrophy

000

NIH

10/24/2022

Issue Date FY: 2022 ( Subtotal = $299,999 )

2022

LIVER COMPANY INC., THE

2671 MARSHALL DR

PALO ALTO

94303-3654

SANTA CLARA

USA

R44DK135174

TLC-1235, a controlled-release mitochondrial protonophore (CRMP), for the reversal of insulin resistance in patients with severe lipodystrophy

000

NIH

9/22/2022

$299,999

All Categories

About

Search

Reports

Data Submission

Recipient Information

ORSOBIO, INC.

Address: 101 JEFFERSON DR MENLO PARK, CA 94025-1114

County: SAN MATEO

Country: UNITED STATES

UEI: QELBLKZEHL99

Issue Date FY Summary

Issue Date FY by OPDIV

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer